In terms of predictive value, few data are available so far regarding the role of PD-L1 status in advanced HCC patients receiving ICIs as monotherapy or part of combinatorial strategies; in addition, not only these data are sparse, but are also conflicting. Here, CD274 is linked to hepatocellular carcinoma.